1369:
1312:
1461:
97:
156:
1417:
1353:
330:
1451:
288:
for "Monoclonal
Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy" at
1441:
34:
739:
1436:
1410:
1346:
1271:
940:
1160:
323:
1456:
797:
724:
629:
1403:
1339:
654:
316:
639:
744:
603:
196:
1288:
382:
847:
1276:
1243:
1184:
1135:
1050:
674:
83:
1214:
1204:
1174:
965:
910:
837:
827:
704:
234:
Oei AL, Moreno M, Verheijen RH, Sweep FC, Thomas CM, Massuger LF, von
Mensdorff-Pouilly S (October 2008).
1446:
1189:
1178:
1140:
1030:
1015:
945:
925:
920:
699:
453:
1040:
900:
669:
634:
1383:
1319:
1155:
1125:
1120:
1105:
935:
782:
734:
694:
339:
184:
118:
44:
27:
393:
877:
428:
388:
289:
265:
764:
583:
257:
192:
73:
1387:
1323:
236:"Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer"
247:
127:
1380:
207:
90:
1376:
1282:
1248:
915:
188:
1430:
1130:
985:
538:
373:
1145:
1110:
1095:
1090:
1085:
1080:
1055:
1010:
1005:
1000:
995:
980:
867:
842:
822:
684:
649:
588:
568:
378:
363:
308:
269:
200:
284:
187:
used to treat cancer. The substance has affinity to various types of cancer, like
1253:
1227:
1222:
1194:
1170:
1165:
1100:
1075:
1065:
1035:
1025:
990:
975:
960:
950:
930:
905:
890:
862:
812:
807:
802:
787:
777:
754:
749:
719:
664:
608:
598:
573:
563:
558:
553:
528:
503:
493:
488:
483:
473:
458:
443:
438:
423:
418:
408:
403:
398:
368:
300:
214:
1368:
1311:
1199:
1150:
1115:
1045:
1020:
970:
955:
895:
885:
857:
832:
772:
709:
644:
624:
578:
548:
543:
533:
523:
518:
508:
498:
468:
463:
433:
413:
203:
138:
1070:
1060:
852:
817:
792:
729:
689:
679:
659:
593:
513:
478:
448:
261:
20:
348:
301:
Antisoma's Lead
Product, Pemtumomab Granted European Orphan Drug Status
56:
252:
235:
181:
49:
61:
312:
206:
into the tumour. As of 2009, it is undergoing Phase III
1391:
1327:
163:
1236:
1213:
876:
763:
617:
356:
347:
137:
117:
112:
96:
82:
72:
67:
55:
43:
33:
26:
126:
1462:Antineoplastic and immunomodulating drug stubs
1411:
1347:
324:
8:
19:
1418:
1404:
1354:
1340:
353:
331:
317:
309:
251:
226:
18:
7:
1365:
1363:
1308:
1306:
1452:Experimental monoclonal antibodies
1390:. You can help Knowledge (XXG) by
1326:. You can help Knowledge (XXG) by
14:
1442:Monoclonal antibodies for tumors
1367:
1310:
199:(PEM or MUC-1) and delivers the
240:International Journal of Cancer
1437:Drugs not assigned an ATC code
1:
197:polymorphic epithelial mucin
1478:
1362:
1305:
1457:Monoclonal antibody stubs
1266:
848:Mirvetuximab soravtansine
153:
1244:Depatuxizumab mafodotin
1185:Tucotuzumab celmoleukin
1136:Rovalpituzumab tesirine
1051:Lorvotuzumab mertansine
941:Clivatuzumab tetraxetan
1322:–related article is a
1205:Vorsetuzumab mafodotin
1161:Tacatuzumab tetraxetan
966:Denintuzumab mafodotin
911:Bivatuzumab mertansine
838:Loncastuximab tesirine
828:Indatuximab ravtansine
705:Naptumomab estafenatox
282:Clinical trial number
1190:Vandortuzumab vedotin
1141:Sacituzumab govitecan
1031:Inotuzumab ozogamicin
1016:Gemtuzumab ozogamicin
946:Cofetuzumab pelidotin
926:Cantuzumab ravtansine
921:Cantuzumab mertansine
740:Nofetumomab merpentan
700:Moxetumomab pasudotox
454:Glembatumumab vedotin
340:Monoclonal antibodies
1237:Chimeric + humanized
1041:Lifastuzumab vedotin
901:Belantamab mafodotin
670:Ibritumomab tiuxetan
635:Anatumomab mafenatox
213:It has been granted
1320:monoclonal antibody
1156:Sofituzumab vedotin
1126:Polatuzumab vedotin
1121:Pinatuzumab vedotin
1106:Oportuzumab monatox
936:Citatuzumab bogatox
798:Derlotuximab biotin
783:Brentuximab vedotin
735:Taplitumomab paptox
725:Satumomab pendetide
695:Nacolomab tafenatox
630:Altumomab pentetate
185:monoclonal antibody
28:Monoclonal antibody
23:
16:Monoclonal antibody
1293:Never to phase III
655:Capromab pendetide
429:Enfortumab vedotin
290:ClinicalTrials.gov
217:status in Europe.
1399:
1398:
1335:
1334:
1303:
1302:
1262:
1261:
584:Tisotumab vedotin
253:10.1002/ijc.23725
193:peritoneal cancer
171:
170:
1469:
1420:
1413:
1406:
1381:immunomodulatory
1371:
1364:
1356:
1349:
1342:
1314:
1307:
1215:Rat/mouse hybrid
354:
333:
326:
319:
310:
303:
298:
292:
280:
274:
273:
255:
231:
167:
166:
159:
130:
24:
22:
1477:
1476:
1472:
1471:
1470:
1468:
1467:
1466:
1427:
1426:
1425:
1424:
1361:
1360:
1304:
1299:
1298:
1283:Clinical trials
1258:
1232:
1209:
872:
759:
613:
343:
337:
307:
306:
299:
295:
281:
277:
233:
232:
228:
223:
208:clinical trials
162:
160:
157:(what is this?)
154:
149:
133:
108:
91:Intraperitoneal
85:
17:
12:
11:
5:
1475:
1473:
1465:
1464:
1459:
1454:
1449:
1444:
1439:
1429:
1428:
1423:
1422:
1415:
1408:
1400:
1397:
1396:
1377:antineoplastic
1372:
1359:
1358:
1351:
1344:
1336:
1333:
1332:
1315:
1301:
1300:
1297:
1296:
1295:
1294:
1291:
1280:
1274:
1268:
1267:
1264:
1263:
1260:
1259:
1257:
1256:
1251:
1249:Duvortuxizumab
1246:
1240:
1238:
1234:
1233:
1231:
1230:
1225:
1219:
1217:
1211:
1210:
1208:
1207:
1202:
1197:
1192:
1187:
1182:
1168:
1163:
1158:
1153:
1148:
1143:
1138:
1133:
1128:
1123:
1118:
1113:
1108:
1103:
1098:
1093:
1088:
1083:
1078:
1073:
1068:
1063:
1058:
1053:
1048:
1043:
1038:
1033:
1028:
1023:
1018:
1013:
1008:
1003:
998:
993:
988:
983:
978:
973:
968:
963:
958:
953:
948:
943:
938:
933:
928:
923:
918:
916:Brontictuzumab
913:
908:
903:
898:
893:
888:
882:
880:
874:
873:
871:
870:
865:
860:
855:
850:
845:
840:
835:
830:
825:
820:
815:
810:
805:
800:
795:
790:
785:
780:
775:
769:
767:
761:
760:
758:
757:
752:
747:
742:
737:
732:
727:
722:
717:
712:
707:
702:
697:
692:
687:
682:
677:
672:
667:
662:
657:
652:
647:
642:
637:
632:
627:
621:
619:
615:
614:
612:
611:
606:
601:
596:
591:
586:
581:
576:
571:
566:
561:
556:
551:
546:
541:
536:
531:
526:
521:
516:
511:
506:
501:
496:
491:
486:
481:
476:
471:
466:
461:
456:
451:
446:
441:
436:
431:
426:
421:
416:
411:
406:
401:
396:
391:
386:
383:+hyaluronidase
376:
371:
366:
360:
358:
351:
345:
344:
338:
336:
335:
328:
321:
313:
305:
304:
293:
275:
246:(8): 1848–53.
225:
224:
222:
219:
189:ovarian cancer
169:
168:
151:
150:
148:
147:
143:
141:
135:
134:
132:
131:
123:
121:
115:
114:
110:
109:
107:
106:
102:
100:
94:
93:
88:
86:administration
80:
79:
76:
70:
69:
65:
64:
59:
53:
52:
47:
41:
40:
37:
31:
30:
15:
13:
10:
9:
6:
4:
3:
2:
1474:
1463:
1460:
1458:
1455:
1453:
1450:
1448:
1445:
1443:
1440:
1438:
1435:
1434:
1432:
1421:
1416:
1414:
1409:
1407:
1402:
1401:
1395:
1393:
1389:
1386:article is a
1385:
1382:
1378:
1373:
1370:
1366:
1357:
1352:
1350:
1345:
1343:
1338:
1337:
1331:
1329:
1325:
1321:
1316:
1313:
1309:
1292:
1290:
1287:
1286:
1284:
1281:
1278:
1275:
1273:
1270:
1269:
1265:
1255:
1252:
1250:
1247:
1245:
1242:
1241:
1239:
1235:
1229:
1226:
1224:
1221:
1220:
1218:
1216:
1212:
1206:
1203:
1201:
1198:
1196:
1193:
1191:
1188:
1186:
1183:
1180:
1176:
1172:
1169:
1167:
1164:
1162:
1159:
1157:
1154:
1152:
1149:
1147:
1144:
1142:
1139:
1137:
1134:
1132:
1131:Rosmantuzumab
1129:
1127:
1124:
1122:
1119:
1117:
1114:
1112:
1109:
1107:
1104:
1102:
1099:
1097:
1094:
1092:
1089:
1087:
1084:
1082:
1079:
1077:
1074:
1072:
1069:
1067:
1064:
1062:
1059:
1057:
1054:
1052:
1049:
1047:
1044:
1042:
1039:
1037:
1034:
1032:
1029:
1027:
1024:
1022:
1019:
1017:
1014:
1012:
1009:
1007:
1004:
1002:
999:
997:
994:
992:
989:
987:
986:Enoblituzumab
984:
982:
979:
977:
974:
972:
969:
967:
964:
962:
959:
957:
954:
952:
949:
947:
944:
942:
939:
937:
934:
932:
929:
927:
924:
922:
919:
917:
914:
912:
909:
907:
904:
902:
899:
897:
894:
892:
889:
887:
884:
883:
881:
879:
875:
869:
866:
864:
861:
859:
856:
854:
851:
849:
846:
844:
841:
839:
836:
834:
831:
829:
826:
824:
821:
819:
816:
814:
811:
809:
806:
804:
801:
799:
796:
794:
791:
789:
786:
784:
781:
779:
776:
774:
771:
770:
768:
766:
762:
756:
753:
751:
748:
746:
743:
741:
738:
736:
733:
731:
728:
726:
723:
721:
718:
716:
713:
711:
708:
706:
703:
701:
698:
696:
693:
691:
688:
686:
683:
681:
678:
676:
673:
671:
668:
666:
663:
661:
658:
656:
653:
651:
648:
646:
643:
641:
638:
636:
633:
631:
628:
626:
623:
622:
620:
616:
610:
607:
605:
602:
600:
597:
595:
592:
590:
587:
585:
582:
580:
577:
575:
572:
570:
567:
565:
562:
560:
557:
555:
552:
550:
547:
545:
542:
540:
539:Pembrolizumab
537:
535:
532:
530:
527:
525:
522:
520:
517:
515:
512:
510:
507:
505:
502:
500:
497:
495:
492:
490:
487:
485:
482:
480:
477:
475:
472:
470:
467:
465:
462:
460:
457:
455:
452:
450:
447:
445:
442:
440:
437:
435:
432:
430:
427:
425:
422:
420:
417:
415:
412:
410:
407:
405:
402:
400:
397:
395:
392:
390:
387:
384:
380:
377:
375:
374:Ascrinvacumab
372:
370:
367:
365:
362:
361:
359:
355:
352:
350:
346:
341:
334:
329:
327:
322:
320:
315:
314:
311:
302:
297:
294:
291:
287:
286:
279:
276:
271:
267:
263:
259:
254:
249:
245:
241:
237:
230:
227:
220:
218:
216:
211:
209:
205:
202:
198:
194:
190:
186:
183:
179:
175:
165:
158:
152:
145:
144:
142:
140:
136:
129:
125:
124:
122:
120:
116:
111:
104:
103:
101:
99:
95:
92:
89:
87:
81:
77:
75:
71:
68:Clinical data
66:
63:
60:
58:
54:
51:
48:
46:
42:
38:
36:
32:
29:
25:
1447:Orphan drugs
1392:expanding it
1374:
1328:expanding it
1317:
1146:Sibrotuzumab
1111:Parsatuzumab
1096:Otlertuzumab
1091:Odronextamab
1086:Ocaratuzumab
1081:Obinutuzumab
1056:Lumretuzumab
1011:Flotetuzumab
1006:Ficlatuzumab
1001:Farletuzumab
996:Etaracizumab
981:Emibetuzumab
868:Zolbetuximab
843:Margetuximab
823:Girentuximab
714:
685:Minretumomab
650:Blinatumomab
589:Teprotumumab
569:Seribantumab
394:Botensilimab
379:Atezolizumab
364:Adecatumumab
296:
283:
278:
243:
239:
229:
212:
201:radioisotope
177:
176:(trade name
173:
172:
161:
155:
1279:from market
1254:Ontuxizumab
1228:Ertumaxomab
1223:Catumaxomab
1195:Vanucizumab
1175:+deruxtecan
1171:Trastuzumab
1166:Tigatuzumab
1101:Onartuzumab
1076:Nimotuzumab
1066:Milatuzumab
1036:Labetuzumab
1026:Imgatuzumab
991:Epcoritamab
976:Emactuzumab
961:Dalotuzumab
951:Dacetuzumab
931:Cirmtuzumab
906:Bevacizumab
891:Alemtuzumab
863:Ublituximab
813:Ensituximab
808:Ecromeximab
803:Dinutuximab
788:Carotuximab
778:Bavituximab
755:Tositumomab
750:Tenatumomab
720:Racotumomab
665:Edrecolomab
640:Arcitumomab
609:Zalutumumab
599:Vantictumab
574:Sugemalimab
564:Robatumumab
559:Rilotumumab
554:Ramucirumab
529:Panitumumab
504:Necitumumab
494:Mapatumumab
489:Lucatumumab
484:Lexatumumab
474:Istiratumab
459:Intetumumab
444:Flanvotumab
439:Figitumumab
424:Dusigitumab
419:Duligotumab
409:Daratumumab
404:Conatumumab
399:Cixutumumab
389:Balstilimab
369:Amivantamab
285:NCT00004115
215:orphan drug
128:646032-04-4
113:Identifiers
74:Trade names
1431:Categories
1200:Veltuzumab
1179:+emtansine
1151:Simtuzumab
1116:Pertuzumab
1046:Lintuzumab
1021:Glofitamab
971:Elotuzumab
956:Demcizumab
896:Axatilimab
886:Abituzumab
858:Siltuximab
833:Isatuximab
773:Amatuximab
745:Pintumomab
715:Pemtumomab
710:Oregovomab
645:Bectumomab
625:Abagovomab
579:Tarextumab
549:Radretumab
544:Pritumumab
534:Patritumab
524:Olaratumab
519:Ofatumumab
509:Nesvacumab
499:Narnatumab
469:Iratumumab
464:Ipilimumab
434:Enoticumab
414:Drozitumab
342:for tumors
221:References
204:Yttrium-90
195:, via the
174:Pemtumomab
139:ChemSpider
119:CAS Number
21:Pemtumomab
1289:Phase III
1277:Withdrawn
1071:Naxitamab
1061:Matuzumab
878:Humanized
853:Rituximab
818:Futuximab
793:Cetuximab
730:Solitomab
690:Mitumomab
680:Lilotomab
660:Detumomab
604:Votumumab
594:Tovetumab
514:Nivolumab
479:Icrucumab
449:Ganitumab
84:Routes of
765:Chimeric
675:Igovomab
262:18661524
178:Theragyn
164:(verify)
98:ATC code
78:Theragyn
270:2287723
180:) is a
1272:WHO-EM
268:
260:
57:Target
45:Source
1375:This
1318:This
618:Mouse
357:Human
349:Tumor
266:S2CID
182:mouse
50:Mouse
1388:stub
1384:drug
1324:stub
258:PMID
191:and
146:none
105:none
62:MUC1
35:Type
1379:or
248:doi
244:123
1433::
1285::
1177:/
264:.
256:.
242:.
238:.
210:.
1419:e
1412:t
1405:v
1394:.
1355:e
1348:t
1341:v
1330:.
1181:)
1173:(
385:)
381:(
332:e
325:t
318:v
272:.
250::
39:?
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.